ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
3,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
4,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
5,2,Headache,Headaches NEC,Headaches,Nerv,N
6,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
7,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
8,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
9,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
10,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
11,1,Pulpless tooth,Dental pulp disorders,Dental and gingival conditions,Gastr,N
12,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
12,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
13,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
13,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
14,1,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
14,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
15,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
16,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
16,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
16,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
17,1,Headache,Headaches NEC,Headaches,Nerv,N
17,2,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
18,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
18,2,Headache,Headaches NEC,Headaches,Nerv,N
18,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,1,Headache,Headaches NEC,Headaches,Nerv,N
20,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
21,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
21,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
21,3,Headache,Headaches NEC,Headaches,Nerv,N
21,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
22,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
23,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
23,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
23,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
23,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
24,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
24,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
24,3,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
24,4,Yawning,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
25,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
26,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
27,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
27,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
27,3,Migraine,Migraine headaches,Headaches,Nerv,N
27,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
27,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
27,6,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
28,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
28,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
29,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
29,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
29,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
30,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
31,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
31,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
33,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
35,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
36,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
37,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
38,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
38,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
40,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
40,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
41,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
42,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
42,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
42,3,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
43,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
44,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
45,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
45,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
45,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
45,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
46,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
46,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
46,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
47,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
48,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
49,1,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
50,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
50,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
51,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
52,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
52,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
52,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
52,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
53,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
53,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
53,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
53,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
54,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
54,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
55,1,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
55,2,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
55,3,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
55,4,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
56,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,1,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
58,1,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
59,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
59,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
59,3,Suffocation feeling,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
60,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
61,1,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
62,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
62,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
63,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
63,2,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
63,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
63,4,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
64,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
65,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
66,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
67,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
68,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
68,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
68,3,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
69,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
70,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
71,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
72,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
72,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
73,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
74,1,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
75,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
75,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
76,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
76,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
76,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
76,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
77,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
77,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
77,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
78,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
79,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
80,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
80,2,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
81,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
82,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
82,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
83,1,Hyperthermia malignant,Body temperature altered,Body temperature conditions,Genrl,Y
83,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
83,3,Organ failure,General signs and symptoms NEC,General system disorders NEC,Genrl,N
84,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
85,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
85,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
85,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
86,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
87,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
88,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
88,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
88,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
88,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
89,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
89,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
89,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
89,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
90,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
91,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
92,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
92,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
93,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
94,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
94,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
94,3,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
94,4,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
95,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
96,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
97,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
98,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
99,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
99,2,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
100,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
101,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
101,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
102,1,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
103,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
103,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
104,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
105,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
105,2,"Delusional disorder, persecutory type",Delusional disorders,Schizophrenia and other psychotic disorders,Psych,N
105,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
105,4,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
105,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
106,1,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
106,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
106,3,Sexual activity increased,Sexuality issues,Gender related factors,SocCi,N
107,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
107,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
107,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
108,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
109,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
110,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
110,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
110,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
110,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
111,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
112,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
113,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
114,1,Spontaneous penile erection,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
115,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
115,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
116,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
117,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
117,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
117,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
117,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
118,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
119,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
119,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
119,3,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
119,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
120,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
120,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
120,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
120,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
120,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
121,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
121,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
122,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
122,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
123,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
124,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
124,2,Gambling disorder,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
125,1,Infusion site abscess,Vascular infections,Infections - pathogen unspecified,Infec,N
125,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
126,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
126,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
126,3,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
126,4,Psychotic behaviour,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
126,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
127,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
128,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
128,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
129,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
129,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
130,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
131,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
132,1,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
132,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
133,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
134,1,Psychotic behaviour,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
135,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
135,2,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
136,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
136,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
137,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
137,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
138,1,Impulse-control disorder,Impulse control disorders,Impulse control disorders NEC,Psych,N
139,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
140,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
141,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
141,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
142,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
142,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
143,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
143,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
143,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
144,1,Attention-seeking behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
144,2,Compulsions,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
144,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
144,4,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
144,5,Gambling,Social issues NEC,Lifestyle issues,SocCi,N
144,6,Libido increased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
145,1,Coombs direct test positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
145,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
145,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
145,4,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
145,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
146,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
146,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
146,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
146,4,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
146,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
146,6,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
147,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
147,2,Infusion site nodule,Infusion site reactions,Administration site reactions,Genrl,N
148,1,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
148,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
149,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
149,2,Infusion site necrosis,Infusion site reactions,Administration site reactions,Genrl,N
149,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
150,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
150,2,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
151,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
151,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
151,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
152,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
152,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
152,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
153,1,Infusion site infection,Vascular infections,Infections - pathogen unspecified,Infec,N
153,2,Infusion site necrosis,Infusion site reactions,Administration site reactions,Genrl,N
154,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
154,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
154,3,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
154,4,Infusion site inflammation,Infusion site reactions,Administration site reactions,Genrl,N
154,5,Infusion site nodule,Infusion site reactions,Administration site reactions,Genrl,N
154,6,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
154,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
155,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
155,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
155,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
156,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
156,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
157,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
157,2,Infusion site nodule,Infusion site reactions,Administration site reactions,Genrl,N
158,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
158,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
158,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
158,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
158,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
159,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
159,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
160,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
160,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
160,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
161,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
162,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
162,2,Infusion site haematoma,Infusion site reactions,Administration site reactions,Genrl,N
162,3,Infusion site infection,Vascular infections,Infections - pathogen unspecified,Infec,N
162,4,Infusion site necrosis,Infusion site reactions,Administration site reactions,Genrl,N
162,5,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
162,6,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
163,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
164,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
164,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
164,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
165,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
165,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
165,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
165,4,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
166,1,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
166,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
166,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
167,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
167,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
167,3,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
167,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
168,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
168,2,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
169,1,Headache,Headaches NEC,Headaches,Nerv,N
169,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
169,3,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
169,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
169,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
170,1,Abdominal wall abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
170,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
170,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
170,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
170,5,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
170,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
171,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
172,1,Blue toe syndrome,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
172,2,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
173,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
173,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
174,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
174,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
174,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
174,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
175,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
176,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
177,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
177,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
177,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
178,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
178,2,Catarrh,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
178,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
178,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
178,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
178,6,Dysphemia,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
178,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
178,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
178,9,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
178,10,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
178,11,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
179,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
179,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
179,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
179,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
179,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
179,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
180,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
180,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
181,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
181,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
181,3,Hypersexuality,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
181,4,Illusion,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
181,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
182,1,Consciousness fluctuating,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
182,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
183,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
184,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
184,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
184,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
184,4,Physical abuse,Criminal activity,Legal issues,SocCi,N
185,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
185,2,Gambling disorder,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
185,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
186,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
186,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
186,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
186,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
187,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
187,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
188,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
188,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
189,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
189,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
190,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
190,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
190,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
190,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
190,5,Headache,Headaches NEC,Headaches,Nerv,N
190,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
190,7,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
190,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
190,9,Myalgia,Muscle pains,Muscle disorders,Musc,N
190,10,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
190,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
191,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
191,2,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
191,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
191,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
191,5,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
191,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
191,7,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
192,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
192,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
192,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
192,4,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
192,5,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
193,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
193,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
194,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
194,2,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
195,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
195,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
195,3,Infusion site necrosis,Infusion site reactions,Administration site reactions,Genrl,N
195,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
195,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
196,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
196,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
196,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
196,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
196,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
197,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
197,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
197,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
197,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
198,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
198,2,Device ineffective,Device issues NEC,Device issues,Prod,N
198,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
198,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
198,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
198,6,Malabsorption from injection site,Injection site reactions,Administration site reactions,Genrl,N
198,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
198,8,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
198,9,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
199,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
199,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
199,3,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
199,4,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
199,5,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
199,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
199,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
199,8,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
200,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
200,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
200,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
200,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
200,5,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
201,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
201,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
202,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
203,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
203,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
204,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
204,2,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
204,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
205,1,Illusion,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
206,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
206,2,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
207,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
207,2,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
208,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
208,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
209,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
209,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
209,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
209,4,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
210,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
210,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
210,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
210,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
211,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
212,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
212,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
213,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
213,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
214,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
215,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
215,2,Malabsorption from injection site,Injection site reactions,Administration site reactions,Genrl,N
215,3,On and off phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
216,1,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
216,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
216,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
217,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
217,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
217,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
217,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
218,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
218,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
218,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
219,1,Complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
219,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
220,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
221,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
222,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
222,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
222,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
222,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
222,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
222,6,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
222,7,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
222,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
223,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
223,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
223,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
223,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
224,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
224,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
225,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
226,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
227,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
227,2,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
227,3,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
228,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
229,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
230,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
230,2,Coombs direct test positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
231,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
231,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
232,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
233,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
233,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
233,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
234,1,Coombs test positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
235,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
236,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
236,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
236,3,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
236,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
236,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
236,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
237,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
237,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
237,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
237,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
237,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
238,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
238,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
238,3,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
239,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
239,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
239,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
239,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
240,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
240,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
241,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
241,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
242,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
243,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
244,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
244,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
244,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
244,4,Lymphoplasmacytoid lymphoma/immunocytoma stage III,Lymphoplasmacytoid lymphomas/immunocytomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
244,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
245,1,Sudden cardiac death,Death and sudden death,Fatal outcomes,Genrl,Y
246,1,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
246,2,On and off phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
247,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
248,1,Camptocormia,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
249,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
249,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
250,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
250,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
250,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
250,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
250,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
250,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
250,7,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
250,8,Yawning,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
251,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
251,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
252,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
252,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
253,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
254,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
254,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
254,3,Jealous delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
254,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
255,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
255,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
255,3,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
255,4,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
255,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
255,6,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
256,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
257,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
258,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
259,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
260,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
261,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
262,1,Ocular neoplasm,Ocular neoplasms malignancy unspecified,Ocular neoplasms,Neopl,N
263,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
263,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
264,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
264,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
264,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
265,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
265,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
265,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
265,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
266,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
266,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
267,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
268,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
268,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
268,3,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
268,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
268,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
269,1,Impulse-control disorder,Impulse control disorders,Impulse control disorders NEC,Psych,N
270,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
270,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
270,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
271,1,Hypersexuality,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
272,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
273,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
273,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
273,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
274,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
274,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
274,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
274,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
275,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
275,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
276,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
276,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
276,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
276,4,Headache,Headaches NEC,Headaches,Nerv,N
276,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
277,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
277,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
277,3,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
277,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
277,5,Illusion,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
277,6,Illusion,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
277,7,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
277,8,On and off phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
277,9,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
277,10,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
277,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
277,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
277,13,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
277,14,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
277,15,Soft tissue mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
278,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
278,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
279,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
279,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
279,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
279,4,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
279,5,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
279,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
279,7,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
279,8,Headache,Headaches NEC,Headaches,Nerv,N
279,9,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
279,10,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
279,11,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
279,12,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
279,13,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
279,14,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
279,15,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
280,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
281,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
281,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
282,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
282,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
282,3,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
282,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
283,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
284,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
284,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
284,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
284,4,On and off phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
285,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
285,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
285,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
285,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
285,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
286,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
287,1,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
287,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
288,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
288,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
288,3,Head banging,Stereotypies and automatisms,Changes in physical activity,Psych,N
288,4,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
288,5,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
289,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
290,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
290,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
290,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
291,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
291,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
291,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
291,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
292,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
292,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
292,3,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
293,1,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
294,1,Infusion site mass,Infusion site reactions,Administration site reactions,Genrl,N
294,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
295,1,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
295,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
296,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
296,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
296,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
296,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
296,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
297,1,Lip erythema,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
297,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
298,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
299,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
299,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
299,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
300,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
300,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
300,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
301,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
301,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
301,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
301,4,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
302,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
302,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
302,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
303,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
303,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
303,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
304,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
305,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
306,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
307,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
308,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
309,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
309,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
309,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
309,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
310,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
310,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
310,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
311,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
312,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
312,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
313,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
314,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
314,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
315,1,Infusion site necrosis,Infusion site reactions,Administration site reactions,Genrl,N
316,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
316,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
317,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
317,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
318,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
318,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
318,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
318,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
319,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
319,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
319,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
319,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
319,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
320,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
320,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
320,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
320,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
320,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
320,6,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
321,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
321,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
321,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
321,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
321,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
322,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
322,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
322,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
322,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
323,1,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
323,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
323,3,Malabsorption from injection site,Injection site reactions,Administration site reactions,Genrl,N
323,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
324,1,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
324,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
324,3,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
324,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
324,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
325,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
326,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
326,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
326,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
326,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
326,5,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
326,6,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
326,7,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
326,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
327,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
328,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
328,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
329,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
329,2,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
330,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
331,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
331,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
332,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
333,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
333,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
333,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
333,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
333,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
333,6,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
334,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
335,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
335,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
335,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
335,4,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
335,5,Hypersexuality,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
335,6,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
335,7,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
336,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
336,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
336,3,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
336,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
336,5,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
337,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
338,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
339,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
339,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
339,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
339,4,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
339,5,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
340,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
341,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
341,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
342,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
343,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
343,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
344,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
344,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
345,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
345,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
346,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
346,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
346,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
347,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
347,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
348,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
349,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
349,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
350,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
351,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
352,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
352,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
353,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
354,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
354,2,Patient dissatisfaction with treatment,Social issues NEC,Lifestyle issues,SocCi,N
355,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
355,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
355,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
355,4,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
355,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
356,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
357,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
358,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
358,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
358,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
359,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
359,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
359,3,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
359,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
359,5,Wrong dose,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
360,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
361,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
361,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
361,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
361,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
361,5,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
361,6,Infusion site nodule,Infusion site reactions,Administration site reactions,Genrl,N
361,7,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
361,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
362,1,Sinus node dysfunction,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
363,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
363,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
363,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
363,4,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
363,5,Product name confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
364,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
364,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
364,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
365,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
366,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
366,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
366,3,Infusion site discharge,Infusion site reactions,Administration site reactions,Genrl,N
366,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
367,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
367,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
367,3,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
367,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
368,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
368,2,Contraindication to medical treatment,Social issues NEC,Lifestyle issues,SocCi,N
368,3,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
368,4,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
368,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
368,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
368,7,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,Y
368,8,Sexually inappropriate behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
369,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
370,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
371,1,Bone erosion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
371,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
371,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
371,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
371,5,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
371,6,Product name confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
372,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
372,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
372,3,Headache,Headaches NEC,Headaches,Nerv,N
372,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
372,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
372,6,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
373,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
373,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
374,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
375,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
376,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
377,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
378,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
379,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
380,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
380,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
381,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
381,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
381,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
381,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
381,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,Y
381,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
382,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
383,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
384,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
384,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
384,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
384,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
384,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,Y
384,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
385,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
385,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
386,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
387,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
388,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
389,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
390,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
390,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
391,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
392,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
393,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
393,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
393,3,Freezing phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
393,4,Infusion site nodule,Infusion site reactions,Administration site reactions,Genrl,N
393,5,Subcutaneous drug absorption impaired,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
394,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,Y
394,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
394,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
395,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
395,2,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
396,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
397,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
397,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
398,1,Intestinal prolapse,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
399,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
399,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
399,3,Freezing phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
399,4,Infusion site nodule,Infusion site reactions,Administration site reactions,Genrl,N
399,5,Subcutaneous drug absorption impaired,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
400,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
400,2,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
400,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
400,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
400,5,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
400,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
400,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
401,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
401,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
401,3,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
401,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
402,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
402,2,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
403,1,Intestinal prolapse,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
404,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
404,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
404,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
404,4,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
405,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
405,2,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
405,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
405,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
405,5,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
405,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
405,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
406,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
407,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
407,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
407,3,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
408,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
408,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
409,1,On and off phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
409,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
410,1,Cardiac failure chronic,Heart failures NEC,Heart failures,Card,N
410,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
410,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
411,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
411,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
412,1,Psychotic behaviour,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
413,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
413,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
414,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
415,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
415,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
416,1,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
416,2,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
416,3,Slow speech,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
417,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
417,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
418,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
418,2,On and off phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
419,1,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
419,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
419,3,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
419,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
419,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
420,1,Injection site ulcer,Injection site reactions,Administration site reactions,Genrl,N
421,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
421,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
421,3,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
421,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
422,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
422,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
422,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
423,1,Administration site bruise,Administration site reactions NEC,Administration site reactions,Genrl,N
424,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
424,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
424,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
424,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
424,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
425,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
426,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
427,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
427,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
427,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
427,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
428,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
428,2,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
429,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
429,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
429,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
429,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
429,5,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
429,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
429,7,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
430,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
431,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
431,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
432,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
433,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
434,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
435,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
436,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
437,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
437,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
437,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
437,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
437,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
438,1,Delusion of reference,Delusional symptoms,Disturbances in thinking and perception,Psych,N
438,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
439,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
440,1,Device issue,Device issues NEC,Device issues,Prod,N
440,2,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
440,3,Infusion site haemorrhage,Infusion site reactions,Administration site reactions,Genrl,N
440,4,Infusion site nodule,Infusion site reactions,Administration site reactions,Genrl,N
441,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
442,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
442,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
442,3,Sudden onset of sleep,Sleep disturbances NEC,Sleep disturbances (incl subtypes),Nerv,N
443,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
443,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
444,1,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
444,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
445,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
446,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
446,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
446,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
446,4,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
446,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
446,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
447,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
448,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
448,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
449,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
449,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
449,3,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
449,4,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
449,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
450,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
450,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
450,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
451,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
451,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
451,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
451,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
452,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
452,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
452,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
452,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
453,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
453,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
453,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
453,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
454,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
454,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
454,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
454,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
455,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
455,2,Impulse-control disorder,Impulse control disorders,Impulse control disorders NEC,Psych,N
456,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
457,1,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
458,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
458,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
458,3,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
458,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
458,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
459,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
460,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
460,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
460,3,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
461,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
462,1,Device leakage,Device issues NEC,Device issues,Prod,N
462,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
462,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
463,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
464,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
464,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
465,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
465,2,Unintentional medical device removal,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
466,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
466,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
467,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
467,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
468,1,Freezing phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
469,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
470,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
471,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
471,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
472,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
472,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
473,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
474,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
474,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
474,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
474,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
474,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
474,6,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
475,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
475,2,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
476,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
476,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
477,1,Device issue,Device issues NEC,Device issues,Prod,N
477,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
477,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
478,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
479,1,Device issue,Device issues NEC,Device issues,Prod,N
479,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
480,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
480,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
481,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
481,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
481,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
481,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
482,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
483,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
483,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
484,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
485,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
485,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
485,3,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
485,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
485,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
485,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
485,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
486,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
486,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
487,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
488,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
489,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
490,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
491,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
491,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
492,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
492,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
493,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
493,2,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
493,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
494,1,Device programming error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
494,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
494,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
495,1,Medical device site rash,Complications associated with device NEC,Complications associated with device,Genrl,N
496,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
496,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
496,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
497,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
497,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
497,3,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
497,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
498,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
498,2,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
498,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
498,4,Freezing phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
499,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
499,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
500,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
501,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
501,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
501,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
502,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
503,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
503,2,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
503,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
504,1,Freezing phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
504,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
504,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
505,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
506,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
506,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
507,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
507,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
508,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
508,2,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
509,1,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
509,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
509,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
510,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
510,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
511,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
511,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
512,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
512,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
512,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
513,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
513,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
513,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
513,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
513,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
514,1,Nasal disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
514,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
514,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
515,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
515,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
516,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
517,1,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
517,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
518,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
518,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
518,3,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
518,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
519,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
519,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
519,3,Soft tissue injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
520,1,Bradykinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
520,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
520,3,Freezing phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
521,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
522,1,Headache,Headaches NEC,Headaches,Nerv,N
523,1,Hypersexuality,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
524,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
524,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
525,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
525,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
526,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
527,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
528,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
529,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
529,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
529,3,Poor quality device used,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
530,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
530,2,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
531,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
532,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
532,2,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
533,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
534,1,Hypersexuality,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
535,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
535,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
536,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
537,1,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
537,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
537,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
537,4,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
537,5,On and off phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
538,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
538,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
539,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
539,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
539,3,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
539,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
539,5,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
540,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
540,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
540,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
540,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
540,5,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
540,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
541,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
541,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
542,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
542,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
542,3,Hypersexuality,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
542,4,Impulse-control disorder,Impulse control disorders,Impulse control disorders NEC,Psych,N
542,5,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
543,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
543,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
544,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
544,2,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
545,1,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
545,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
545,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
546,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
547,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
548,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
548,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
549,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
549,2,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
549,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
549,4,Shoulder fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
550,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
550,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
551,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
551,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
552,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
553,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
553,2,Application site nodule,Application site reactions,Administration site reactions,Genrl,N
554,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
554,2,On and off phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
554,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
555,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
555,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
555,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
556,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
556,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
556,3,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
556,4,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
556,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
556,6,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
557,1,Administration site bruise,Administration site reactions NEC,Administration site reactions,Genrl,N
557,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
558,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
558,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
558,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
558,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
558,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
559,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
559,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
560,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
560,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
560,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
561,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
561,2,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
561,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
561,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
562,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
562,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
562,3,On and off phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
563,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
563,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
563,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
564,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
564,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
564,3,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
564,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
564,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
564,6,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
565,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
565,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
566,1,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
567,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
567,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
567,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
567,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
567,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
567,6,Initial insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
568,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
568,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
568,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
